Barbara J Clark Selected Research

Cytoplasmic and Nuclear Receptors (Nuclear Receptors)

2/2016	Polychlorinated Biphenyl-Xenobiotic Nuclear Receptor Interactions Regulate Energy Metabolism, Behavior, and Inflammation in Non-alcoholic-Steatohepatitis.
1/2016	Nuclear receptors and nonalcoholic fatty liver disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Barbara J Clark Research Topics

Disease

6	Neoplasms (Cancer) 01/2018 - 01/2002
3	Obesity 01/2018 - 01/2016
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2018 - 09/2017
2	Non-alcoholic Fatty Liver Disease 09/2017 - 01/2016
2	Inflammation (Inflammations) 02/2016 - 01/2016
2	Insulin Resistance 02/2016 - 01/2016
2	Hepatocellular Carcinoma (Hepatoma) 06/2015 - 07/2014
1	Acute Kidney Injury (Acute Renal Failure) 06/2021
1	Hypertension (High Blood Pressure) 10/2018
1	Chronic Fatigue Syndrome (Myalgic Encephalomyelitis) 01/2018
1	Acne Vulgaris 01/2018
1	Virilism (Virilization) 01/2018
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2018
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2018
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2018
1	Adrenal Insufficiency (Adrenal Gland Hypofunction) 01/2018
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2018
1	Mitochondrial Diseases (Mitochondrial Disease) 02/2016
1	Fatty Liver 02/2016
1	Alcoholic Fatty Liver 02/2016
1	Dyslipidemias (Dyslipidemia) 01/2016
1	Fibrosis (Cirrhosis) 01/2016
1	Confusion (Bewilderment) 01/2016
1	Breast Neoplasms (Breast Cancer) 10/2013
1	Hypophosphatemia 04/2013
1	Primary Hyperparathyroidism 04/2013

Drug/Important Bio-Agent (IBA)

3	Dehydroepiandrosterone (DHEA)IBA 01/2018 - 07/2014
3	XenobioticsIBA 09/2017 - 01/2016
2	Environmental Pollutants (Pollutants, Environmental)IBA 09/2017 - 02/2016
2	Polychlorinated Biphenyls (PCBs)IBA 09/2017 - 02/2016
2	LipidsIBA 02/2016 - 03/2012
2	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 02/2016 - 01/2016
2	LigandsIBA 01/2016 - 03/2012
2	Proteins (Proteins, Gene)FDA Link 03/2012 - 01/2002
1	Cisplatin (Platino)FDA LinkGeneric 06/2021
1	indole-3-carbinolIBA 10/2018
1	Cytochrome P-450 CYP1A1 (CYP1A1)IBA 10/2018
1	aroclor 1260IBA 02/2016
1	AroclorsIBA 02/2016
1	Glucose (Dextrose)FDA LinkGeneric 02/2016
1	CytokinesIBA 02/2016
1	Retinoid X Receptors (Retinoid X Receptor)IBA 01/2016
1	GTP-Binding Proteins (G-Protein)IBA 06/2015
1	Estrogen ReceptorsIBA 06/2015
1	Dehydroepiandrosterone SulfateIBA 07/2014
1	Ouabain (G Strophanthin)IBA 10/2013
1	Vacuolar Proton-Translocating ATPases (V-Type ATPase)IBA 10/2013
1	Adenosine Triphosphatases (ATPase)IBA 10/2013
1	Cardiac GlycosidesIBA 10/2013
1	PotassiumIBA 10/2013
1	Bromodeoxyuridine (BrdU)IBA 10/2013
1	SaltsIBA 04/2013
1	Phospholipids (Phosphatides)FDA LinkGeneric 03/2012
1	OxysterolsIBA 03/2012
1	CholesterolIBA 03/2012
1	SphingolipidsIBA 03/2012
1	Fatty Acids (Saturated Fatty Acids)IBA 03/2012
1	Co-Repressor ProteinsIBA 01/2006
1	steroidogenic acute regulatory proteinIBA 01/2006
1	Cyclic AMP Response Element ModulatorIBA 03/2005
1	Transcription Factors (Transcription Factor)IBA 03/2005
1	Messenger RNA (mRNA)IBA 01/2002
1	Oligonucleotide ProbesIBA 01/2002
1	DNA (Deoxyribonucleic Acid)IBA 01/2002
1	Cyclic AMP Response Element-Binding Protein (Cyclic AMP-Responsive DNA-Binding Protein)IBA 01/2002
1	Progesterone FDA LinkGeneric 01/2002

Therapy/Procedure

1	Therapeutics 01/2016